{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:09:53Z","timestamp":1792393793070,"version":"4.4.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1,6]]},"abstract":"<jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Cowden syndrome is a rare autosomal dominant disease characterized by the development of hamartomas and increased risks of other tumors, including breast, thyroid, and uterine cancers. Most patients with Cowden syndrome show mutations of the phosphatase and tensin homolog (PTEN) gene on chromosome 10; however, some patients with mutations do not show clinical symptoms, while patients with clinical symptoms may not have detectable PTEN mutations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation:<\/jats:title>\n            <jats:p>A 39-year-old woman with macrocephaly had previously been diagnosed with Cowden syndrome at another hospital, when she presented with the onset of breast cancer. A wide variety of complications were detected, including cerebellar tumors treated by resection, hydrocephalus, and multiple polyps in the stomach and large intestine. She was further diagnosed with adult-onset Lhermitte\u2013Duclos disease as a complication of Cowden syndrome. She subsequently developed a dural arteriovenous fistula treated by transvenous embolization. After transfer to our hospital, she developed adenomatous goiter treated by resection, recurrent breast cancer treated with hormonal therapy, and multifocal oral mucosal papillomatosis. Her older sister had previously been diagnosed with Cowden syndrome and her father was undiagnosed but had macrocephaly, hydrocephalus, and multifocal oral mucosal papillomatosis, suggestive of Cowden syndrome. After consultation with a genetic specialist, analysis of the PTEN gene showed a rare but likely pathogenic germline c.801\u2009+\u20092T&gt;A variant located at the splice donor site of intron 7. The patient\u2019s clinical diagnosis of Cowden syndrome was accordingly confirmed by the genetic findings. Appropriate surveillance procedures were put in place to detect any further tumors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The clinical symptoms of Cowden syndrome do not always correlate with the genetic results. However, recent improvements in genetic testing suggest the importance of diagnosing this disease using both clinical and genetic approaches, in collaboration with genetic experts, to ensure an accurate diagnosis and appropriate surveillance for malignant tumors.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000032572","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T19:05:09Z","timestamp":1673031909000},"page":"e32572","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Clinical and genetic diagnosis of Cowden syndrome: A case report of a rare PTEN germline variant and diverse clinical presentation"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2026-1307","authenticated-orcid":false,"given":"Hironori","family":"Arai","sequence":"first","affiliation":[{"name":"Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, Narita, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiwamu","family":"Akagi","sequence":"additional","affiliation":[{"name":"Department of Molecular Diagnosis and Cancer Prevention, Saitama Cancer Center, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Japanese Red Cross Narita Hospital, Narita, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhide","family":"Onai","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Japanese Red Cross Narita Hospital, Narita, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Utsu","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, Narita, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, Narita, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Aotsuka","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, Narita, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ng0596-114","article-title":"Localization of the gene for Cowden disease to chromosome 10q22-23.","volume":"13","author":"Nelen","year":"1996","journal-title":"Nat Genet"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/jmg.37.11.828","article-title":"Will the real Cowden syndrome please stand up: revised diagnostic criteria.","volume":"37","author":"Eng","year":"2000","journal-title":"J Med Genet"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/jmg.2004.018036","article-title":"Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome.","volume":"41","author":"Pilarski","year":"2004","journal-title":"J Med Genet"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/sj.ejhg.5200289","article-title":"Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations.","volume":"7","author":"Nelen","year":"1999","journal-title":"Eur J Hum Genet"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/jnci\/djt277","article-title":"Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria.","volume":"105","author":"Pilarski","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10689-013-9674-3","article-title":"Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome.","volume":"13","author":"Nieuwenhuis","year":"2014","journal-title":"Fam Cancer"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1086\/377109","article-title":"Germline PTEN promoter mutations and deletions in Cowden\/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase\/Akt pathway.","volume":"73","author":"Zhou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1093\/hmg\/ddab175","article-title":"Redefining the PTEN promoter: identification of novel upstream transcription start regions.","volume":"30","author":"Grencewicz","year":"2021","journal-title":"Hum Mol Genet"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nature10275","article-title":"A continuum model for tumour suppression.","volume":"476","author":"Berger","year":"2011","journal-title":"Nature"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41580-018-0015-0","article-title":"The functions and regulation of the PTEN tumour suppressor: new modes and prospects.","volume":"19","author":"Lee","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/1078-0432.CCR-11-2283","article-title":"Lifetime cancer risks in individuals with germline PTEN mutations.","volume":"18","author":"Tan","year":"2012","journal-title":"Clin Cancer Res"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1200\/JCO.2013.53.6656","article-title":"Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations.","volume":"32","author":"Ngeow","year":"2014","journal-title":"J Clin Oncol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ajhg.2010.11.013","article-title":"A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands.","volume":"88","author":"Tan","year":"2011","journal-title":"Am J Hum Genet"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-med-052218-125823","article-title":"The clinical spectrum of PTEN mutations.","volume":"71","author":"Yehia","year":"2020","journal-title":"Annu Rev Med"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s004390000317","article-title":"Effect of nonsense mutations on PTEN mRNA stability.","volume":"107","author":"Raizis","year":"2000","journal-title":"Hum Genet"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/hmg\/7.3.507","article-title":"Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.","volume":"7","author":"Marsh","year":"1998","journal-title":"Hum Mol Genet"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/humu.23288","article-title":"Characterization of cryptic splicing in germline PTEN intronic variants in Cowden syndrome.","volume":"38","author":"Chen","year":"2017","journal-title":"Hum Mutat"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, Version 2.2021, NCCN clinical practice guidelines in oncology.","volume":"19","author":"Daly","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.2217\/fon-2022-0305","article-title":"A phase II study of TAS-117 in patients with advanced solid tumors harboring germline PTEN-inactivating mutations.","volume":"18","author":"Rodon","year":"2022","journal-title":"Future Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032572","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:31:51Z","timestamp":1746325911000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,6]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000032572","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,6]]}}}